Growth Metrics

10x Genomics (TXG) Acquisitions (2021 - 2022)

10x Genomics recorded quarterly Acquisitions of $2.5 million in Q4 2022, up 66.67% quarter-over-quarter from $1.5 million in Q3 2022.

10x Genomics' Acquisitions history runs 2 years deep, the most recent figure standing at $2.5 million for Q4 2022.

  • In Q4 2022, Acquisitions changed N/A year-over-year to $2.5 million; the TTM figure through Dec 2023 stood at $4.0 million (changed 0.0% YoY), while the FY2022 annual figure was $4.0 million, down 26.62% from the prior year.
  • Acquisitions came in at $2.5 million for Q4 2022 at 10x Genomics, up from $1.5 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $5.5 million in Q1 2021 to a low of $1.5 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 42.20 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 2.50 Mn
Sep 30, 2022 1.50 Mn
Mar 31, 2021 5.45 Mn